160 related articles for article (PubMed ID: 22009481)
1. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro.
Cheung BB; Koach J; Tan O; Kim P; Bell JL; D'andreti C; Sutton S; Malyukova A; Sekyere E; Norris M; Haber M; Kavallaris M; Cunningham AM; Proby C; Leigh I; Wilmott JS; Cooper CL; Halliday GM; Scolyer RA; Marshall GM
J Pathol; 2012 Feb; 226(3):451-62. PubMed ID: 22009481
[TBL] [Abstract][Full Text] [Related]
2. TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.
Marshall GM; Bell JL; Koach J; Tan O; Kim P; Malyukova A; Thomas W; Sekyere EO; Liu T; Cunningham AM; Tobias V; Norris MD; Haber M; Kavallaris M; Cheung BB
Oncogene; 2010 Nov; 29(46):6172-83. PubMed ID: 20729920
[TBL] [Abstract][Full Text] [Related]
3. TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells.
Sutton SK; Koach J; Tan O; Liu B; Carter DR; Wilmott JS; Yosufi B; Haydu LE; Mann GJ; Thompson JF; Long GV; Liu T; McArthur G; Zhang XD; Scolyer RA; Cheung BB; Marshall GM
Oncotarget; 2014 Oct; 5(20):10127-39. PubMed ID: 25333256
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis.
Sutton SK; Cheung BB; Massudi H; Tan O; Koach J; Mayoh C; Carter DR; Marshall GM
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2241-2250. PubMed ID: 31342168
[TBL] [Abstract][Full Text] [Related]
5. TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization.
Bell JL; Malyukova A; Kavallaris M; Marshall GM; Cheung BB
Cell Cycle; 2013 Mar; 12(6):889-98. PubMed ID: 23422002
[TBL] [Abstract][Full Text] [Related]
6. TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway.
Qi L; Lu Z; Sun YH; Song HT; Xu WK
Int J Mol Med; 2016 Dec; 38(6):1734-1742. PubMed ID: 27748839
[TBL] [Abstract][Full Text] [Related]
7. TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells.
Kim PY; Rahmanto AS; Tan O; Norris MD; Haber M; Marshall GM; Cheung BB
Apoptosis; 2013 May; 18(5):639-51. PubMed ID: 23404198
[TBL] [Abstract][Full Text] [Related]
8. Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells.
Tan H; Qi J; Chu G; Liu Z
Oncol Res; 2017 Apr; 25(4):551-558. PubMed ID: 27737724
[TBL] [Abstract][Full Text] [Related]
9. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
[TBL] [Abstract][Full Text] [Related]
10. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members.
Bell JL; Malyukova A; Holien JK; Koach J; Parker MW; Kavallaris M; Marshall GM; Cheung BB
PLoS One; 2012; 7(5):e37470. PubMed ID: 22629402
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.
Wang N; Zhang T
Oncol Res; 2018 Aug; 26(7):1005-1014. PubMed ID: 29295721
[TBL] [Abstract][Full Text] [Related]
12. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
[TBL] [Abstract][Full Text] [Related]
13. High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.
Kim PY; Tan O; Liu B; Trahair T; Liu T; Haber M; Norris MD; Marshall GM; Cheung BB
Cancer Lett; 2016 May; 374(2):315-23. PubMed ID: 26902425
[TBL] [Abstract][Full Text] [Related]
14. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Zheng L; Zhao Z; Rong L; Xue L; Song Y
J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
[TBL] [Abstract][Full Text] [Related]
15. The estrogen-responsive B box protein is a novel regulator of the retinoid signal.
Cheung BB; Bell J; Raif A; Bohlken A; Yan J; Roediger B; Poljak A; Smith S; Lee M; Thomas WD; Kavallaris M; Norris M; Haber M; Liu HL; Zajchowski D; Marshall GM
J Biol Chem; 2006 Jun; 281(26):18246-56. PubMed ID: 16636064
[TBL] [Abstract][Full Text] [Related]
16. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
17. Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway.
Yao J; Xu T; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncol Rep; 2016 Feb; 35(2):1204-12. PubMed ID: 26718507
[TBL] [Abstract][Full Text] [Related]
18. Co-overexpression of Bag-1 and heat shock protein 70 in human epidermal squamous cell carcinoma: Bag-1-mediated resistance to 5-fluorouracil-induced apoptosis.
Wood J; Pring M; Eveson JW; Price N; Proby CM; Hague A
Br J Cancer; 2011 Apr; 104(9):1459-71. PubMed ID: 21522149
[TBL] [Abstract][Full Text] [Related]
19. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
[TBL] [Abstract][Full Text] [Related]
20. The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells.
Schönrath K; Klein-Szanto AJ; Braunewell KH
PLoS One; 2012; 7(3):e33116. PubMed ID: 22479362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]